Clinical Trial Update: Reduced Clavulanate Formulation of Amoxicillin-Clavulanate in Children 6-23 Months With Acute Otitis Media [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated a reduced clavulanate formulation of amoxicillin-clavulanate in children 6-23 months with acute otitis media; results completed and po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Media

Drugs mentioned

• amoxicillin-clavulanate (amoxicillin-clavulanate)

Snippet

Sponsor: Nader Shaikh | Conditions: Acute Otitis Media | Phase 3 | Status: COMPLETED | Results posted: 2018-01-03